Célia is a post-doctoral research scientist in the Lysosomal Health in Ageing group, Hopwood Centre for Neurobiology, Lifelong Health Theme, at SAHMRI.

She completed her PhD in Bordeaux, France, where she investigated the role of neuroinflammation in emotional and cognitive alterations associated with obesity under the supervision of Dr Nathalie Castanon. She showed that inflammation, and particularly TNF-α, could be an important target in the treatment of mood disorders in obese individuals (Fourrier et al, 2018; Fernandez de Cossio et al, 2018). In addition, she investigated the effect of nutritional interventions with specific nutrients (i.e. n-3 polyunsaturated fatty acids and antioxidants) on metabolic, mood and cognitive alterations in inflammatory conditions (Larrieu et al, 2014) and on the regulation of inflammatory processes in the brain (Fourrier et al. 2017).

During a first postdoctoral position, under the guidance of Prof Bernhard T Baune in the Discipline of Psychiatry at the University of Adelaide, her research activities encompassed a new approach to personalised psychiatry with a focus on the role of the immune system in psychiatric disorders. From 2017 to 2019, she coordinated a clinical trial that investigated the efficacy of using an antidepressant augmented with an anti-inflammatory medication in the treatment of major depressive disorder.

Célia started a second postdoctoral position at SAHMRI in 2019 under the guidance of Dr Tim Sargeant. Her current research focuses on how the relationships between the immune syste and the lysosomal system can be targeted in neurodegenerative disease such as Alzheimer's disease.